The Food and Drug Administration (FDA) approved a generic version of the abortion pill mifepristone in October, making chemical abortion more affordable and accessible to pregnant women who wish to ...

A significant majority of American voters say they would rather elect a Democrat than a Republican to represent them in Congress in next year’s midterms, according to the latest Marist Poll. The ...

Before government shutdowns end, political blame games begin. And as politicians from both parties try to blame each other, party operatives and pundits scour the poll data to see who wins the game.

Abstract: Mobile Crowdsensing (MCS) has become a popular sensing paradigm, where a number of participants use their mobile devices to collectively share and extract information related to a certain ...

Share on Pinterest The FDA recently approved a generic abortion pill that’s considered as safe and effective as mifepristone. Shuran Huang for The Washington Post via Getty Images The approval, ...

The FDA has approved a second generic version of oral mifepristone, used to terminate pregnancy, after determining it is identical to the branded drug. The FDA Thursday approved generic mifepristone ...

WASHINGTON (AP) — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and ...

AbbVie (NYSE:ABBV) announced on Thursday that the company has reached settlements with all generic drugmakers to resolve litigation that challenged their plans to introduce copycat versions of Rinvoq, ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. America’s generic drug market is one of our greatest health ...

Lupin is introducing bosentan tablets for oral suspension, 32 mg in the United States. This follows the approval received by Lupin’s alliance partner, NATCO for its Abbreviated New Drug Application ...

Dr. Reddy 's Laboratories is betting big on a new wave of growth fueled by a global demand for weight-loss drugs — by launching its own lower-cost version of semaglutide, the blockbuster ingredient ...